Our courses, including the sought-after PG Diploma in Clinical Research, ensure that our students are well-prepared to drive the complex terrain of clinical trials. In this article, we will decode the ...
Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...
Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and ...
Updated Phase 1 data presented at ESH-iCMLf 26th Annual John Goldman ConferenceReported cumulative MMR rate of 44% (8/18) by 24 weeks, with ...
Additional positive data from the Company’s completed Phase 1 clinical trial evaluating ENTR-601-44 reinforces its safety profile and supports ...
Istaroxime is a novel first-in-class investigational therapy that is intended to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining ...
The Phase I/II trials for rare forms of hereditary blindness further confirmed the potential for gene therapy treatments of ...
An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...
Kezar’s ongoing Phase 2a PORTOLA clinical trial of zetomipzomib ... to zetomipzomib or Kezar’s clinical trials. Many factors may cause differences between current expectations and actual ...
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting ...
The investigational IL-17A inhibitor izokibep was found to induce clear clinical responses in people with moderate to severe ...
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback